Rett syndrome is a neurological, X chromosomal-linked disorder associated with mutations in the MECP2 gene. MeCP2 protein has been proposed to play a role in transcriptional regulation as well as in chromatin architecture. Since MeCP2 mutant cells exhibit surprisingly mild changes in gene expression, we have now explored the possibility that Rett mutations may affect the ability of MeCP2 to bind and organize chromatin. We found that all but one of the 21 missense MeCP2 mutants analyzed accumulated at heterochromatin and about half of them were significantly affected. Furthermore, two-thirds of all mutants showed a significantly decreased ability to cluster heterochromatin. Three mutants containing different proline substitutions (P101H, P101R and P152R) were severely affected only in heterochromatin clustering and located far away from the DNA interface in the MeCP2 methyl-binding domain structure. MeCP2 mutants affected in heterochromatin accumulation further exhibited the shortest residence time on heterochromatin, followed by intermediate binding kinetics for clustering impaired mutants. We propose that different interactions of MeCP2 with methyl cytosines, DNA and likely other heterochromatin proteins are required for MeCP2 function and their dysfunction lead to Rett syndrome.
INTRODUCTION
Rett syndrome (RTT, MIM 312750) is a post-natal neurological disorder, with an incidence of 1/10 000 female births. The females develop normally until 6 -18 months of age, but after that, the growth is drastically slowed down, followed by the development of stereotypical hand movements, autistic behavior, loss of speech and motoric skills, respiratory disorders etc. Mutations in the chromosome Xq28 region corresponding to the MECP2 gene have been shown to be linked to the disease (1) .
MeCP2 recognizes methylated cytosines (5 mC) via a highly conserved methyl-cytosine-binding domain (MBD) and is concentrated in the densely methylated pericentric heterochromatin (2) . It has also been shown to contribute to transcriptional regulation via its transcriptional repression domain (TRD) interaction with histone deacetylases (3, 4) . In addition to its role in regulating gene expression, we have recently shown that the MBD of MeCP2 has the ability to reorganize and cluster heterochromatin in vivo (5, 6) . MeCP2 has accordingly been described to compact nucleosomal arrays in vitro (7) .
Several types of MECP2 gene mutations including deletions and also duplications have been found in Rett patients (8, 9) . Whereas the most common mutations, the missense mutations, are mostly clustered within the MBD (amino acids 78-162), the majority of nonsense mutations occur after the MBD predominantly within the TRD (amino acids 207-310; Fig. 1A ). In view of the random nature of X chromosome inactivation in females and, hence, the chimeric pattern of cells expressing wild-type or mutant MeCP2, genotype -phenotype correlations are rather complex (10) .
Surprisingly, MeCP2 null mice showed unexpectedly mild gene expression changes, strengthening the relevance of other MeCP2 chromatin functions (11) . Similar results were obtained from samples of Rett patients (12, 13) . In this regard, MeCP2 mutations have recently been shown to affect DNA binding, its capacity to induce compaction of nucleosomal arrays (7, 14) as well as its chromatin binding kinetics (15, 16) . However, the mechanism and regulation of MeCP2-induced higher-order heterochromatin organization is still unclear.
In this study, we have systematically characterized 21 missense Rett MeCP2 mutants in terms of their ability to bind and aggregate pericentric heterochromatin and found several which severely affected one or both of these MeCP2 properties. (20) . Structural data were displayed and annotated using PyMOL software (http://pymol.sourceforge.net/; last accessed: 15.08.2011). The residues that directly interact with the two 5 mC are shown in cyan and the Rett mutations included in our study in pink. Bottom panel: the Rett mutations analyzed are listed (in pink) above the corresponding wild-type amino acid within the sequence of MeCP2 MBD. The location of the defined a-helix (a1), b-strands (b1 and b2) and loops/ Asx-ST motif (bold black line) is illustrated below the protein sequence (19, 20) . (B) Representative maximum intensity projections generated from Z-stacks of mouse myoblasts expressing wild-type MeCP2 and mutants thereof. DNA was counterstained with DAPI. PC, phase contrast. Scale bar: 5 mm. (C) The plot shows the fold accumulation at chromocenters of 21 Rett mutants, wild-type MeCP2 and GFP in mouse myoblasts. Asterisks represent statistically significant difference in regard to the wild-type:
* P , 0.05; * * P , 0.001. All mutants accumulated significantly different (P ≤ 0.05) with respect to GFP alone (not shown). The experiment was repeated at least two times with 10 cells per mutant evaluated each time.
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RESULTS AND DISCUSSION
Based on our finding that the MBD of MeCP2 clusters heterochromatin and most Rett missense mutations affect this domain, we set out to investigate whether they were impaired in binding to and/or clustering heterochromatin. We selected Pmi28 mouse myoblasts as our cellular assay system. This cell line was used before to characterize the dose-dependent effect of wild-type MeCP2 on the spatial organization of chromocenters and it expresses very low to undetectable level of endogenous wild-type MeCP2 (5). Moreover, it showed a stable and nearly normal karyotype, with minimal variations in chromocenter number caused by variable numerical chromosome aberrations.
We used mammalian expression constructs containing the mutant human MeCP2e2 isoform cDNAs fused at the Cterminus of the enhanced green fluorescent protein (GFP) coding sequence (17) . All missense mutations within the MBD are highlighted in pink in Figure 1A , and the mutated forms of the wild-type residues are indicated above the sequence alignment. Intranuclear localization of the fusion proteins and the induction of chromocenter clustering in transfected cells were assessed by epifluorescence microscopy using AT-selective DNA dyes [Hoechst 33258, DAPI (4
to independently visualize pericentric heterochromatin. As MeCP2 strongly accumulates in these heterochromatic regions, we visualize them as a proxy for how (Rett) mutations in the MECP2 gene can change its ability to associate with chromatin and to reorganize it.
We first tested these MeCP2 Rett mutants for their protein accumulation at the chromocenters by taking a ratio of average mean intensity of protein bound at chromocenters versus nucleoplasm. The results indicate that all the mutant proteins showed enrichment at chromocenters (ratio was .1), but to very different extents (Fig. 1B and C) . R111G mutant protein accumulated to the lowest extent. This mutant has been shown before to exhibit complete loss of function of MeCP2 and to no longer repress Sp1-mediated transcriptional activation of methylated and unmethylated promoters (17) . We found that it mislocalizes to the nucleoli (phase-dense regions in Fig. 1B ) instead of pericentric heterochromatin, which was further confirmed by staining with the nucleolar marker B23 (data not shown). Concomitantly to the lack of heterochromatin association, this mutant depicted an increased nucleoplasmic pool apparent from the high diffuse signal throughout the nucleus (Fig. 1B) . F155S exhibited a similar subcellular distribution and a deficit in the heterochromatin accumulation (Supplementary Material, Fig. S1 ). Except for P101H, R133H, E137G and A140V, all the other analyzed mutant proteins accumulated at chromocenters less than the wild-type, with more than half significantly affected in their accumulation ability when compared with wild-type (Fig. 1C) .
Since several mutants associated less efficiently with heterochromatin, we further addressed whether they would be impaired in their ability to cluster heterochromatin in vivo.
To assess the degree of heterochromatin clustering in a quantitative manner, we scored the number of chromocenters in cells expressing either GFP-tagged wild-type or mutant MeCP2. By this assay, we address the ability of these proteins to reorganize heterochromatin architecture. In Figure 2 , the clustering potential of the proteins is displayed as cumulative frequency curves, which represent the percentage of nuclei with up to a certain number of chromocenters. Cells expressing the Rett mutants P101H, P101R and P152R showed a highly significant increase in chromocenter numbers compared with wild-type MeCP2-expressing cells (Fig. 2 ). R111G and F155S mutants had the most dramatic effect with completely abolished chromocenter clustering ( Fig. 2C and Supplementary Material, Fig. S1 ). Additionally, 10 more mutants exhibited significantly decreased clustering abilities in comparison with wild-type MeCP2 (Fig. 2B) . In contrast, the other mutants behaved similarly to the wild-type. Among them is the A140V exchange that has been reported in association with very mild clinical symptoms (18) . Altogether, two-thirds of the Rett MeCP2 missense MBD mutants were significantly affected in clustering potential compared with wild-type MeCP2.
We further tested whether the clustering ability of selected mutants was also conserved in human cells. We performed immunostaining in combination with fluorescence in situ hybridization using three DNA probes simultaneously to detect the major pericentric heterochromatin regions that are present in chromosomes 1, 9 and 16 (Supplementary Material, Fig. S2A and B) of human cells expressing either wild-type or mutant MeCP2. The outcome of this analysis essentially confirms the results obtained in mouse cells.
Next, we tested whether the clustering of chromocenters generally reflected the amount of protein that accumulated at these regions. Hence, we plotted the median of chromocenter number versus the average accumulation at chromocenters (Fig. 3A) . Mutants falling onto an arbitrary line connecting the negative GFP alone control and the positive wild-type MeCP2 control show an inverse correlation between binding to chromocenters and corresponding numbers of chromocenters, i.e. binding less is accompanied by less clustering. The majority of the mutants were both affected in their binding to chromocenters and in clustering chromocenters (Fig. 3A , pink and blue). This could be a consequence of impaired binding affecting their ability to cluster or, alternatively, these mutations could independently affect both properties. Interestingly, some mutants (P101R, P101H and P152R) were mildly to non-affected in heterochromatin binding but severely affected in clustering of chromocenters (Fig. 3A , green). When we applied the same color code to label the corresponding residues in the MBD structure, these residues mapped to the outer part of the MBD (Fig. 3B ). Both residues are located adjacent to structured motifs [P101 to b-sheet 1 (b1) and P152 to a-helix 1 (a1)] and within loops (19, 20) .
As it has been previously shown that some Rett mutations affected chromatin binding kinetics of MeCP2 in vivo (15,16), we performed in situ detergent extraction as well as fluorescence photobleaching (FRAP) recovery experiments on mutants affected in either chromatin clustering, binding or both. We chose the A140V mutant that was affected neither in binding nor in clustering of chromatin, P101H which was affected only in clustering and R133L affected in both functions (Fig. 4A) . The R133L mutation resulted in higher extractability and a much faster FRAP recovery, Human Molecular Genetics, 2011, Vol. 20, No. 21 4189
probably reflecting disruption of binding to 5 mC (Fig. 4B and  C) . A minimal level of 5 mC seems to be required as a priming event for efficient accumulation of MeCP2 at heterochromatin, as shown by the lack of chromocenter localization of a GFP-tagged MBD fusion in Dnmt1/3a/3b triple knock-out cells (21) . Our live-cell kinetic data indeed indicated that although the R133L mutant MeCP2 was still able to accumulate at heterochromatin to a lower extent, it interacted only very transiently and with low affinity. Very similar FRAP kinetics were recently reported for a different mutation of this residue, R133C (15) . Both substitutions had comparable heterochromatin clustering potential (Figs 2 and 3 ), although the R133L exhibited a somehow lower ability to accumulate at heterochromatin (Figs 1 and 3) . The in vivo accumulation of this mutant at chromatin may be either the result of retaining low-affinity recognition of 5 mC and/or binding to DNA or other heterochromatin-associated proteins. On the other extreme, the A140V mutant protein performed in both assays (in situ extraction and FRAP kinetics) as the wild-type ( Fig. 4B and C) . Importantly, the P101H mutant, which accumulated as the wild-type at heterochromatin but was drastically impaired in clustering chromocenters, had intermediate FRAP kinetics and was also easier to extract from heterochromatin. The FRAP kinetics follow the same trend for the different mutants independently of whether the region photobleached included only chromocenters ( Fig. 4C ; which measures mostly the contribution of heterochromatinbound MeCP2) or half of the nucleus ( Fig. 4C ; with a Fig. S2C ).
Since the P101 is located far away from the 5 mC interacting pocket, these data suggest that it is primordially involved in connecting chromatin fibers most likely through interactions with other chromatin proteins. From all the MBD residues, the P101 seems particularly sensitive to any substitution (Fig. 1A) . Whereas mutations to L, S and T have a mild heterochromatin clustering effect, substitution to positively charged residues (R or H) results in a drastic effect. This residue is located in the NH 2 -terminal part of the MBD and likely induces a sharp turn before the two opposing b-sheets (b1 and b2, Fig. 1 ). Interference with this rigid proline-induced conformation may be more significant on replacement with the not very flexible histidine and less with the other more malleable amino acids. The same could apply for the P152 substitution to the basic residue R.
In summary, our analysis of the in vivo chromocenter clustering ability of the different mutations clearly indicated that all mutants where this property was significantly disrupted mapped to the same outer surface of the MBD structure and, significantly, these mutants were not concomitantly affected in chromatin binding per se. From the chromocenter accumulation analysis, we conclude that such mutants should be able to bind well to DNA/chromatin in vivo, but could be affected in interactions to other heterochromatin proteins and, thus, could not induce chromocenter clustering resulting in faster FRAP kinetics. When compared with other chromatin binders, the FRAP kinetics of wild-type MeCP2 are much faster than the core histone components (22) but close to the kinetics of the linker histone H1 (23, 24) . Indeed, both MeCP2 and histone H1 compete for binding to nucleosomes in vitro (25, 26) and bind to the linker DNA (14, 27, 28) . Moreover, MeCP2 is able to condense chromatin in vitro to the same level as histone H1 and under physiological salt concentrations (7). These in vitro data suggest that MeCP2 can 'cross-link' chromatin fibers together as is the case with the linker histone H1. On the other hand, other stereotypical heterochromatin proteins, such as HP1a, are highly mobile and have a much faster exchange on chromatin (Supplementary Material, Fig. S3 ) (29 -32) . We have previously shown that MeCP2 but not HP1a clusters chromatin in vivo (5,6) and our present data suggest that mutations occurring in Rett patients are defective in the chromatin architecture function of MeCP2.
We therefore propose that proteins involved in the formation and stabilization of higher-order chromatin structures ('chromatin linkers') bind to chromatin through multiple modes of interactions including, in the case of MeCP2, interactions with 5 mC, DNA and other chromatin proteins and have a longer residence time on chromatin. The latter might also conversely facilitate the establishment of multiple higherorder contacts in a self-reinforcing loop. We suggest that the cooperation of all these binding modes, which individually may have low affinity, promotes ultimately stable association of MeCP2 at heterochromatin, measured in the FRAP and in situ extraction experiments. This stable binding could facilitate connections within and between chromatin fibers and lead to a dynamic yet stable organization of heterochromatin 
MATERIALS AND METHODS

Expression plasmids
Expression vectors encoding GFP-tagged fusions of human wild-type or mutant MeCP2 cDNA cloned into the pEGFP-C1 vector were described before (17) as was GFP-HP1a (32).
Cell culture, transfection and staining
Pmi28 mouse myoblasts were cultured as described (33) . Cells were plated on glass coverslips or multiwell dishes (ibidi m-dishes 8 well; Ibidi GmbH, Munich, Germany) prior to transfection for fixed cell or live cell experiments, respectively. Cells were transfected using TransFectin TM (Bio-Rad, Hercules, CA, USA) following the manufacturer's protocol. Cultures were fixed and DNA stained as described (6) . In short, cultures were rinsed in phosphate-buffered saline (PBS) and fixed in 3.7% formaldehyde in PBS. Nuclear DNA was counterstained using TOPRO-3 (Invitrogen, Carlsbad, CA, USA), Hoechst 33258 or DAPI, and samples were mounted in vectashield antifading medium (Vector Laboratories, Burlingame, CA, USA) or moviol.
Microscopy and image analysis
For chromocenter counting, cells were fixed and examined on a Zeiss Axiovert 200 epifluorescence microscope. Image stacks (0.5 mm Z-interval) were acquired with a 63× Plan-Apochromatic NA 1.4 or 40× Plan-Neofluar NA 1.3 oil immersion phase contrast objectives and a PCO Sensicam QE cooled CCD camera. The image stacks were analyzed using a semi-automated approach. For this, we developed a custom application using the priithon platform. Image stacks were treated as three-dimensional volumes and segmented displaying an optical section view and a maximum intensity Z-projection. Nuclei and chromocenters were automatically identified by intensity-based thresholding and implementation of the water algorithm (34) . Identified nuclei and chromocenters were outlined and numbered and the performance of the algorithm was controlled by visual inspection using optical section views and maximum intensity Z-projections. Parameters were adjusted to account for different sample brightness and chromocenter density. All intermediate images, parameters and counting results were automatically saved. Cumulative frequencies of chromocenter numbers were tested for statistical significance utilizing the Kolmogorov -Smirnov test.
To assess the chromocenter binding ability, we collected confocal Z stacks (voxel size: 0.05 × 0.05 × 0.3 mm) of formaldehyde-fixed cells expressing similar levels of the GFP fusion protein on either Zeiss LSM510Meta or Leica SP5 confocal microscopes, using 63×/1.4 NA oil objective and 405 nm diode pumped solid state (for Hoechst 33258, DAPI), 488 nm Argon (for GFP) and 633 nm He-Ne (TOPRO-3) laser excitation. Care was taken in selecting the imaging conditions to avoid under-and overexposed pixels, while keeping the imaging conditions constant. Heterochromatic foci were identified by counterstaining with TOPRO-3, Hoechst 33258 or DAPI. Image analysis was performed using ImageJ version 1.38× (http://rsb.info.nih.gov/ij; last accessed: 15.08.2011). The average mean intensity at the chromocenters versus the nucleoplasm was assessed by selecting four regions of equal size in the two compartments, calculating the mean fluorescent intensity in each compartment and then taking the ratio between both. The formula used to calculate the accumulation of MeCP2 and mutants at chromocenters for each construct was:
Accumulation at chromocenter = average mean intensity at chromocenters average mean intensity in nucleoplasm
In the case of chromocenter binding assays, statistical significance was checked through the t-test.
In situ extraction of GFP-tagged wild-type MeCP2 and MeCP2-bearing mutants was done by transfecting the cells plated on ibidi dishes with the respective construct and extracting them directly on the microscope while imaging. Cells were first washed with PBS containing 0.5 mM MgCl 2 , 0.5 mM CaCl 2 and imaged. Then, the solution was changed to PBS containing 0.5 mM MgCl 2 , 0.5 mM CaCl 2 and 0.5% Triton X-100. Confocal Z-series were recorded over time on a Zeiss LSM510Meta confocal microscope, using 63×/1.4 NA oil objective. The microscope was equipped with a microscope cage incubation chamber (Oko-lab, Ottaviano, Italy) and the temperature was maintained at 378C. GFP was excited with the 488 nm argon laser line. Confocal Z-stacks were acquired with a frame size of 1024 × 1024 pixels (voxel size: 0.20 × 0.20 and 1.0 mm), at 2 min time intervals for 14 min. Quantitative evaluation was performed using ImageJ. The mean fluorescence intensities at the chromocenters for each cell and time point were calculated for PBS and PBS-Triton X-100. First, using ImageJ 'adjust threshold' plug-in, the chromocenters were identified and then 'create selection' plug-in was used to assess the mean fluorescence intensity only at chromocenters. This procedure was repeated for each cell and time point. The whole data set for each cell was then normalized to the mean fluorescence intensities of the chromocenters before extraction with Triton X-100. The results were evaluated using Microsoft Excel and plotted using Microsoft Excel or Origin 7.5 software (Origin Lab Corp.).
Fluorescence recovery after photobleaching
Live cell imaging and FRAP experiments were performed on an on a LSM510Meta confocal microscope (Zeiss) using a 63×/1.4NA Plan-Apochromat oil immersion objective. The microscope was maintained at 378C with the help of an Oko-lab cage incubation chamber. Confocal image series were recorded with a frame size of 512 × 512 pixels (pixel size: 60 nm) and at 2 s time intervals; 488 nm argon laser Human Molecular Genetics, 2011, Vol. 20, No. 21 4193 line (25 mW) was used at 100% transmission to bleach and at 0.05% transmission to record GFP-tagged proteins over time, with the pinhole opened to 3 Airy units. Either a whole chromocenter or half of the nucleus was photobleached, and 5 -10 pre-bleach and 250 -400 post-bleach frames were recorded for each time-series. Quantitative evaluation was performed using ImageJ and Microsoft Excel. Briefly, the time-series was first corrected for translational movements using 'stackreg' plug-in from ImageJ and the analysis of the FRAP data was performed exactly as described (35) .
Supplemental figures:
Figure S1 Probes were added to the cells and sealed with rubber cement to decrease evaporation of the probe over night. They were then denatured simultaneously at 75 °C for 5 minutes and hybridized over night at 37 °C. Non-hybridized probe was washed off using 50% formamide in SSC at 45 °C three times followed by two washes with 2xSSC. DNA was counterstained with DAPI and the cells were mounted using vectashield. and Cy5 (excited at 633 nm) signals for whole DNA and chromosomes 1, 9 and 16 pericentric heterochromatin regions, respectively, were acquired on a Leica SP5 laser scanning microscope using a 63x/1.4NA oil objective.
FISH signals were counted manually through these stacks. 3D rendering was done using UCSF chimera (www.cgl.ucsf.edu/chimera). 
